163 related articles for article (PubMed ID: 31386786)
1. Visualization of sequential conversion of human intermediately reprogrammed stem cells into iPS cells.
Teshigawara R; Hirano K; Nagata S; Huang D; Tada T
Genes Cells; 2019 Oct; 24(10):667-673. PubMed ID: 31386786
[TBL] [Abstract][Full Text] [Related]
2. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
3. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
4. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
Greder LV; Post J; Dutton JR
Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of human somatic reprogramming to iPS cell.
Teshigawara R; Cho J; Kameda M; Tada T
Lab Invest; 2017 Oct; 97(10):1152-1157. PubMed ID: 28530648
[TBL] [Abstract][Full Text] [Related]
6. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.
Ahmed TA; Shousha WG; Abdo SM; Mohamed IK; El-Badri N
Cell Physiol Biochem; 2020 Apr; 54(2):271-286. PubMed ID: 32233339
[TBL] [Abstract][Full Text] [Related]
7. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
Zhang L; Wang Y; Zhang Y; Wang L; Huang H
Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
9. Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.
Marthaler AG; Adachi K; Tiemann U; Wu G; Sabour D; Velychko S; Kleiter I; Schöler HR; Tapia N
Sci Rep; 2016 Jan; 6():19415. PubMed ID: 26762895
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
11. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.
Heng JC; Feng B; Han J; Jiang J; Kraus P; Ng JH; Orlov YL; Huss M; Yang L; Lufkin T; Lim B; Ng HH
Cell Stem Cell; 2010 Feb; 6(2):167-74. PubMed ID: 20096661
[TBL] [Abstract][Full Text] [Related]
12. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
13. Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.
Im I; Son YS; Jung KB; Kang I; Teh BE; Lee KB; Son MY; Kim J
J Biol Chem; 2019 Dec; 294(49):18547-18556. PubMed ID: 31570522
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
17. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
18. Generation of Mouse-Induced Pluripotent Stem Cells by Lentiviral Transduction.
Liu X; Chen J; Firas J; Paynter JM; Nefzger CM; Polo JM
Methods Mol Biol; 2019; 1940():63-76. PubMed ID: 30788818
[TBL] [Abstract][Full Text] [Related]
19. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
